Stock screenerAll disclosures →
EDGAR →
DMAC
Conviction 29HealthcareScan · Thu, Jun 25, 2026DMAC$6.14-3.46%
ResistanceSupportVol 14Vol MA14 192.26K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price6.14
Change-3.46%
Gap+3.22%
Rel volume1.12×
Avg volume180.32K
Avg $ vol1.04M
SMA 205.80
SMA 506.06
SMA 2007.17
Price vs 50+1.35%
Price vs 200-14.33%
MA stackmixed
50/200 cross—
Supertrenddown · 6.40
RSI (14)56
MACD hist0.10
MACD crossbull · 6d
Stoch %K / %D61 / 78
ADX (14)17
+DI / −DI26 / 17
RSI divergenceBullish
MACD divergenceBullish
ATR %+5.93%
ADR %6.10%
52w high9.39
52w low3.57
From 52w high-34.61%
Above 52w low+71.99%
New 52w highNo
SqueezeOff
Bollinger width18.73%
%B0.82
Donchian pos61.09%
Donchian high6.71
Donchian low5.25
AVWAP (52w high)7.48
vs AVWAP high-17.86%
AVWAP (52w low)6.79
vs AVWAP low-9.53%
OBV trendFlat
Chaikin MF (20)-0.15
Today vs 20d1.12×
Avg vol (14d)192.26K
Avg vol (20d)180.32K
Avg $ vol (20d)1.04M
Market cap330.84M
RS 3m (vs SPY)-19.95%
RS 6m (vs SPY)-32.74%
RS line new highNo
Trend template4/8
Technical rank37.1
1 week+7.16%
1 month-2.85%
3 months-10.50%
6 months-27.25%
1 year+64.61%
YTD-22.57%
P/E-10.10
P/B7.00
P/S661.69
P/FCF-11.37
EPS-0.6500
Div yield—
ROE-69.37%
ROA-61.73%
Debt/Eq—
Current9.11
EV/EBITDA—
Gross margin—
Net margin—
Rev growth0.00%
EPS growth-34.05%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value325.98M
Revenue500K
Net income-10.04M
Gross profit—
Free cash flow-29.1M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out53.88M
Employees35
ListedThu, Nov 29, 2007
Free float23.38M
Float %44.9%
Short interest4.87M
Days to cover30.4d
Short volume44.9%
Squeeze score70 / 100
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction29 / 100
Pattern quality—
Tech rank37.1 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance6.54
Support5.30
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in DMAC
No recent disclosed trades by Congress in DMAC. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in DMAC · 9 buys
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Kuntz Richard Director · Stock Option (right to buy) · 2026-06-01 | Grant | 40.41K | $0 | 2026-06-01 | 2026-06-03 |
Parsons James T. Director · Stock Option (right to buy) · 2026-06-01 | Grant | 51.19K | $0 | 2026-06-01 | 2026-06-03 |
Semba Charles Pauling Director · Stock Option (right to buy) · 2026-06-01 | Grant | 40.41K | $0 | 2026-06-01 | 2026-06-03 |
Giuffre Randall Michael Director · Stock Option (right to buy) · 2026-06-01 | Grant | 40.41K | $0 | 2026-06-01 | 2026-06-03 |
Kellen Scott CFO & Secretary · Stock Option (right to buy) · 2026-06-01 | Grant | 162K | $0 | 2026-06-01 | 2026-06-03 |
O'Connor Daniel J. Director · Stock Option (right to buy) · 2026-06-01 | Grant | 40.41K | $0 | 2026-06-01 | 2026-06-03 |
Krop Julie Chief Medical Officer · Stock Option (right to buy) · 2026-06-01 | Grant | 67.5K | $0 | 2026-06-01 | 2026-06-03 |
Lewis Tanya Director · Stock Option (right to buy) · 2026-06-01 | Grant | 40.41K | $0 | 2026-06-01 | 2026-06-03 |
Pauls Dietrich John President & CEO · Stock Option (right to buy) · 2026-06-01 | Grant | 380K | $0 | 2026-06-01 | 2026-06-03 |
SEC filings
EDGAR filings in DMAC
No recent SEC filings on file for DMAC.
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.